InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,321.41
(
0.00%
)
US TECH 100
18,238.40
(
0.04%
)
Dow Jones
39,872.99
(
0.00%
)
Brent Oil
81.90
(
-0.66%
)
Bitcoin
69,846.08
(
-0.41%
)
Post# of 251889
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Whalatane

Send PM Follow Ignore
Followers 120
Posts 20346
Boards Moderated 0
Alias Born 06/13/2011

Whalatane

Member Level

Re: None

Tuesday, 04/11/2023 6:24:32 PM

Tuesday, April 11, 2023 6:24:32 PM

Post# of 251889
KDNY. my interest in this Co is their IgaN drug ,Atrasentan , which is in P 3 with a read out late Q4 2023
Here are some recent comments on the safety of this drug ( relevant due to a voluntary hold in a P1 KDNY is running with a different drug CHK-336 )

https://www.streetwisereports.com/article/2023/04/05/safety-data-from-one-trial-of-new-drug-helpful-to-another.html

Not a recommendation . Do your own DD etc etc

Opposing opinions welcomed .....

Kiwi
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up